Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes
Arthritis Research & Therapy, 08/12/09
Tat SK et al. – Study provides data on the presence and role of ephrin B2/EphB4 receptors in human chondrocytes/cartilage. Data showed that ephrin B2 treatment positively impacts the abnormal metabolism of osteoarthritic (OA) cartilage by inhibiting important catabolic factors involved in this disease at the same time as increasing anabolic activity.
Methods- An investigation of the possible implication of ephrin B2/EphB4 receptors on the catabolic/anabolic activities of human OA chondrocytes
- EphB4 receptor and ephrin B2 levels were determined by qPCR and IHC
- Effects of ephrin B2 on the expression/production of factors involved in the OA process were determined
- EphB4 receptors and ephrin B2 ligands are expressed and produced by human normal and OA chondrocytes
- Ephrin B2 protein was found at similar levels in both cartilage types
- Whereas EphB4 receptor expression and production levels were increased in OA chondrocytes/cartilage
- Ephrin B2 treatment inhibited the IL-1beta, IL-6, MMP-1, MMP-9, MMP-13, and proteinase-activated receptor-2 (PAR-2) gene expression levels
- However, MMP-2 was unaffected, and significantly increased collagen type II, a cartilage specific macromolecule
- It also inhibited the IL-1beta stimulated protein production of IL-6, MMP-1 and MMP-13
Related Articles
The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion
International Journal of Cancer, 11/10/09
Relevance Score: 68%
Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine and streptozotocin-induced hyperalgesia
Pharmacological Reports, 10/12/09
Relevance Score: 65%
Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: Inhibition of interleukin-1beta-induced nuclear factor-kappaB-mediated inflammation and apoptosis
Arthritis Research & Therapy, 11/11/09
Relevance Score: 64%
Update on therapeutic developments for hereditary angioedema
Allergy and Asthma Proceedings, 10/12/09
Relevance Score: 64%
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis
Arthritis Research & Therapy, 11/20/09
Relevance Score: 63%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
Clinical Rheumatology, 12/10/09
The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes
Arthritis & Rheumatism, 12/10/09
HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: A genome-wide association study in Koreans with replication in North Americans
Arthritis & Rheumatism, 12/10/09
Today in Osteoarthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
The morbid anatomy of "erosive osteoarthritis" of the interphalangeal finger joints. an optimized scoring system to monitor disease progression in affected joints
Annals of Rheumatic Diseases, 12/10/09
Insurer and out-of-pocket costs of osteoarthritis in the US: Evidence from national survey data
Arthritis & Rheumatism, 12/10/09
Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis
Annals of Rheumatic Diseases, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


